Tata Institute has come with drugs to stop cancer recurrence
Researchers at the Tata Institute in Mumbai
announced the development of a novel drug aimed at preventing cancer
recurrence, according to a report by Hindustan
Times. The researchers and doctors at the institute have reportedly worked
for 10 years and have now come up with a tablet which they claimed would stop
the occurrence of cancer for the second time in patients.
The tablet is priced at ₹100 per piece, according to Business
Standard.
“We did a little experiment
in which we took human breast cancer cells and implanted them in
immunodeficient mice," said Dr Indraneel Mittra, the
onco-surgeon-turned-scientist who led the TMH doctors in the study, as quoted
by Hindustan Times.
“Within six weeks, a small tumour was formed. We divided the mice into three
categories according to the cancer treatment—chemotherapy, radiotherapy and
surgery. We found that all the three treatments increased chromatin in the
mouse brain."
“We found that a combination of
resveratrol and copper helped in destroying chromatin. We used the combination
to be given orally in our studies and found that it prevented metastasis,"
said Dr Mittra, who added that while this was the outcome of the experiment on
mice, the team would now do human trials, as per the HT report.
Dr Mittra joined TMH in 1982 as the country’s first “surgeon scientist".
Mittra further explained that after confirming the
presence of chromatin particles following cancer treatment, the team’s focus
shifted towards reducing treatment-related toxicity (side effects) in various
human cancers, such as stomach, brain, oral, and blood cancers through clinical
trials, as per the Hindustan
Times report.
No comments:
Post a Comment